245822007	245822007	CD	B-NP	O
|	|	NN	I-NP	O
CBH	CBH	NN	I-NP	O
|	|	NN	I-NP	O
84425024	84425024	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0068288	0068288	CD	B-NP	O
|	|	CC	I-NP	O
10/29/2004	10/29/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/1/2004	9/1/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/4/2004	2/4/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
HARBY	HARBY	NN	B-NP	O
,	,	,	O	O
RAPHAEL	RAPHAEL	NN	B-NP	O
563-82-33-0	563-82-33-0	CD	I-NP	O
Eu	Eu	NNP	I-NP	O
,	,	,	I-NP	O
Florida	Florida	NNP	I-NP	O
07720	07720	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
7/14/04	7/14/04	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
SNF/rehab	SNF/rehab	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ANTAL	ANTAL	NNP	B-NP	O
,	,	,	O	O
FABIAN	FABIAN	NNP	B-NP	O
YONG	YONG	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	NNP	B-NP	O
code	code	VBP	B-VP	O
Incomplete	Incomplete	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALBUTEROL	ALBUTEROL	NN	B-NP	B-protein
INHALER	INHALER	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NNP	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Wheezing	Wheezing	NNP	I-NP	O
ECASA	ECASA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/2/04	3/2/04	CD	B-NP	O
by	by	IN	B-PP	O
GROUT	GROUT	NNP	B-NP	O
,	,	,	O	O
DANA	DANA	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
73838606	73838606	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
DIGOXIN	DIGOXIN	NN	B-NP	O
0.125	0.125	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
DILTIAZEM	DILTIAZEM	NN	I-NP	O
SUSTAINED	SUSTAINED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	B-protein
90	90	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	B-VP	O
55	55	CD	B-NP	O
,	,	,	O	O
call	call	NN	B-NP	O
HO	HO	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/2/04	3/2/04	CD	B-NP	O
by	by	IN	B-PP	O
PIZZITOLA	PIZZITOLA	NNP	B-NP	O
,	,	,	O	O
AARON	AARON	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TOPROL	TOPROL	NN	B-NP	B-protein
XL	XL	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
02154038	02154038	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
IRON	IRON	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
PROZAC	PROZAC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FLUOXETINE	FLUOXETINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/2/04	3/2/04	CD	B-NP	O
by	by	IN	B-PP	O
DAPONTE	DAPONTE	NNP	B-NP	O
,	,	,	O	O
ELBERT	ELBERT	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
04891646	04891646	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FLUOXETINE	FLUOXETINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/2/04	3/2/04	CD	B-NP	O
by	by	IN	B-PP	O
ARMON	ARMON	NNP	B-NP	O
,	,	,	O	O
CRISTOBAL	CRISTOBAL	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
FLUOXETINE	FLUOXETINE	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LASIX	LASIX	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
,	,	,	O	O
call	call	NN	B-NP	O
HO	HO	NN	I-NP	O
if	if	IN	B-SBAR	O
held	hold	VBN	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/2/04	3/2/04	CD	B-NP	O
by	by	IN	B-PP	O
LAROCQUE	LAROCQUE	NN	B-NP	O
,	,	,	O	O
AMADO	AMADO	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
70838958	70838958	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Sulfa	Sulfa	NNP	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
600	600	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/2/04	3/2/04	CD	B-NP	O
by	by	IN	B-PP	O
PIONTKOWSKI	PIONTKOWSKI	NNP	B-NP	O
,	,	,	O	O
ASA	ASA	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
NPH	NPH	NNP	I-NP	O
HUMULIN	HUMULIN	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	B-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
40	40	CD	I-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QAM	QAM	NNP	I-NP	I-DNA
;	;	:	O	I-DNA
20	20	CD	B-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QPM	QPM	NNP	I-NP	I-DNA
SC	SC	NNP	I-NP	I-DNA
40	40	CD	I-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QAM	QAM	NNP	I-NP	I-DNA
20	20	CD	I-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QPM	QPM	NNP	I-NP	I-DNA
Instructions	Instruction	NNPS	I-NP	I-DNA
:	:	:	O	O
1/2	1/2	CD	B-NP	O
dose	dose	NN	I-NP	O
if	if	IN	B-SBAR	O
NPO	NPO	NNP	B-NP	B-protein
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/2/04	3/2/04	CD	B-NP	O
by	by	IN	B-PP	O
COLLELLA	COLLELLA	NN	B-NP	O
,	,	,	O	O
TRACY	TRACY	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
04891646	04891646	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/2/04	3/2/04	CD	B-NP	O
by	by	IN	B-PP	O
RIJO	RIJO	NNP	B-NP	O
,	,	,	O	O
RANDOLPH	RANDOLPH	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
41599435	41599435	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/2/04	3/2/04	CD	B-NP	O
by	by	IN	B-PP	O
FRAME	FRAME	NNP	B-NP	O
,	,	,	O	O
RICH	RICH	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
13395076	13395076	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/2/04	3/2/04	CD	B-NP	O
by	by	IN	B-PP	O
SCHUBACH	SCHUBACH	NNP	B-NP	O
,	,	,	O	O
SIMON	SIMON	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-protein
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	O
instructs	instruct	NNS	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/2/04	3/2/04	CD	B-NP	O
by	by	IN	B-PP	O
STUTSMAN	STUTSMAN	NN	B-NP	O
,	,	,	O	O
VAN	VAN	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
41599435	41599435	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/2/04	3/2/04	CD	B-NP	O
by	by	IN	B-PP	O
BRANDOM	BRANDOM	NNP	B-NP	O
,	,	,	O	O
RAY	RAY	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SUST	SUST	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

25	25	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	B-VP	O
55	55	CD	B-NP	O
,	,	,	O	O
call	call	NN	B-NP	O
HO	HO	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/2/04	3/2/04	CD	B-NP	O
by	by	IN	B-PP	O
SCHETROMPF	SCHETROMPF	NN	B-NP	B-protein
,	,	,	O	O
RODNEY	RODNEY	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
250	250	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/21	10/21	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
iron	iron	NN	I-NP	O
products	product	NNS	I-NP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/2/04	3/2/04	CD	B-NP	O
by	by	IN	B-PP	O
WOWK	WOWK	NN	B-NP	B-protein
,	,	,	O	O
RALEIGH	RALEIGH	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FLUOXETINE	FLUOXETINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SALMETEROL	SALMETEROL	NNP	B-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ADVAIR	ADVAIR	NNP	I-NP	O
DISKUS	DISKUS	NNP	I-NP	O
500/50	500/50	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/2/04	3/2/04	CD	B-NP	O
by	by	IN	B-PP	O
GALYON	GALYON	NN	B-NP	B-protein
,	,	,	O	O
GALE	GALE	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
04891646	04891646	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SALMETEROL	SALMETEROL	NNP	B-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/2/04	3/2/04	CD	B-NP	O
by	by	IN	B-PP	O
BERGET	BERGET	NNP	B-NP	O
,	,	,	O	O
CLINTON	CLINTON	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
SALMETEROL	SALMETEROL	NNP	I-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
NEXIUM	NEXIUM	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
diabetic	diabetic	JJ	B-NP	O
diet	diet	NN	I-NP	O
/	/	SYM	B-NP	O
2	2	CD	I-NP	O
gm	gm	NN	I-NP	O
Na	Na	NN	I-NP	O
/	/	SYM	B-VP	O
ADA	ADA	NN	B-NP	O
2000	2000	CD	I-NP	O
cals/day	cals/day	NN	I-NP	O
/	/	SYM	B-NP	O
Low	Low	NN	I-NP	O
saturated	saturate	VBD	B-VP	O
fat	fat	JJ	B-NP	B-protein
low	low	JJ	I-NP	I-protein
cholesterol	cholesterol	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
I	I	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FDI	FDI	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
ACTIVITY	ACTIVITY	NNP	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Eric	Eric	NNP	B-NP	O
Weatherall	Weatherall	NNP	I-NP	O
1	1	CD	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
Vasular	Vasular	NNP	B-NP	O
lab	lab	NNP	I-NP	O
June	June	NNP	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
7/12/04	7/12/04	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Reginald	Reginald	NNP	B-NP	O
Graue	Graue	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
Codeine	Codeine	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Fatigue	Fatigue	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
anemia	anemia	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
COPD	COPD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CAD	CAD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Diabetes	Diabetes	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
cabg	cabg	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cardiac	cardiac	JJ	B-ADJP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	B-protein
surgery	surgery	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
renal	renal	JJ	I-NP	I-protein
artery	artery	NN	I-NP	I-protein
stenosis	stenosis	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
renal	renal	JJ	I-NP	I-protein
artery	artery	NN	I-NP	I-protein
stenosis	stenosis	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
s/p	s/p	NN	I-NP	I-protein
renal	renal	JJ	I-NP	I-protein
artery	artery	NN	I-NP	I-protein
stent	stent	JJ	I-NP	I-protein
afib	afib	JJ	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
atrial	atrial	JJ	I-NP	I-protein
fibrillation	fibrillation	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
CHF	CHF	NN	I-NP	I-protein
diastolic	diastolic	JJ	I-NP	I-protein
dysfn	dysfn	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
?	?	.	O	O

IPF	IPF	NN	B-NP	O
glaucoma	glaucoma	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
glaucoma	glaucoma	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
73F	73F	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
mult	mult	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
including	include	VBG	B-PP	O
CAD	CAD	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
and	and	CC	O	O
mult	mult	JJ	B-NP	O
PCI	PCI	NNP	I-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
Afib	Afib	NNP	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
p/w	p/w	VBP	B-VP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
fatigue/malaise	fatigue/malaise	NN	B-NP	O
.	.	.	O	O

Only	Only	RB	B-NP	O
localizing	localize	VBG	I-NP	O
sx	sx	NN	I-NP	O
is	be	VBZ	B-VP	O
cough	cough	NN	B-NP	O
productive	productive	JJ	I-NP	O
of	of	IN	B-PP	O
blood-streaked	blood-streaked	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
nausea	nausea	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
sx	sx	NN	I-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
med	me	VBN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

Meds	Med	NNS	B-NP	O
:	:	:	O	O
asa	asa	NN	B-NP	O
,	,	,	O	O
lasix	lasix	NN	B-NP	O
,	,	,	O	O
dilt	dilt	NN	B-NP	O
,	,	,	O	O
dig	dig	NN	B-NP	O
,	,	,	O	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
toprol	toprol	NN	B-NP	O
XL	XL	NN	I-NP	O
,	,	,	O	O
zocor	zocor	NN	B-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
,	,	,	O	O
prozac	prozac	NN	B-NP	O
,	,	,	O	O
advair	advair	NN	B-NP	O
,	,	,	O	O
glucovance	glucovance	NN	B-NP	O
,	,	,	O	O
gemfibrozil	gemfibrozil	NN	B-NP	O
SH	SH	NN	I-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
pack	pack	NN	I-NP	O
yr	yr	NN	I-NP	O
smoking	smoking	NN	I-NP	O
hx	hx	NN	I-NP	O
,	,	,	O	O
quit	quit	NN	B-NP	O
1983	1983	CD	I-NP	O
.	.	.	O	O

VS	VS	NNS	B-NP	O
:	:	:	O	O
Afebrile	Afebrile	NN	B-NP	O
,	,	,	O	O
VSS	VSS	NN	B-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
JVP	JVP	NN	B-NP	B-protein
7	7	CD	I-NP	I-protein
,	,	,	O	O
fine	fine	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
B	B	NN	I-NP	O
bases	base	NNS	I-NP	O
,	,	,	O	O
2/6	2/6	CD	B-NP	O
SEM	SEM	NN	I-NP	O
at	at	IN	B-PP	O
base	base	NN	B-NP	O
,	,	,	O	O
abd	abd	NN	B-NP	O
benign	benign	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	O
:	:	:	O	O
WBC	WBC	NNP	B-NP	O
13	13	CD	I-NP	O
,	,	,	O	O
Hct	Hct	NN	B-NP	O
31	31	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
baseline	baseline	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Cr	Cr	NNP	B-NP	O
1.7	1.7	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
from	from	IN	B-PP	O
1.4	1.4	CD	B-NP	O
-RRB-	-RRB-	HYPH	B-ADJP	O
,	,	,	O	O
LFTs	LFT	NNS	B-NP	B-protein
nl	nl	NN	I-NP	I-protein
,	,	,	O	O
Lipase	Lipase	NN	B-NP	O
177	177	CD	I-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
2.9	2.9	CD	I-NP	I-protein
,	,	,	O	O
Dig	Dig	NNP	B-NP	O
1.0	1.0	CD	I-NP	O
,	,	,	O	O
enzymes	enzyme	NNS	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-DNA
@	@	NN	I-NP	I-DNA
65	65	CD	I-NP	I-DNA
,	,	,	O	O
old	old	JJ	B-NP	O
inf	inf	NN	I-NP	O
and	and	CC	O	O
anterosept	anterosept	VBD	B-VP	O
Q	Q	NNP	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
dig	dig	NN	B-NP	O
effect	effect	NN	I-NP	O
seen	see	VBN	B-VP	O
in	in	IN	B-PP	O
lateral	lateral	JJ	B-NP	O
leads	lead	NNS	I-NP	O
-LRB-	-LRB-	TO	B-PP	O
unchanged	unchanged	JJ	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CXR	CXR	NN	I-NP	O
:	:	:	O	O
BLL	BLL	NN	B-NP	O
opacities	opacity	NNS	I-NP	O
c/w	c/w	VBP	B-VP	O
PNA	PNA	NN	B-NP	B-protein
vs.	vs.	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
fibrotic	fibrotic	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

RUQ	RUQ	NN	B-NP	O
U/S	U/S	NN	I-NP	O
:	:	:	O	O
non-obstructing	non-obstructing	JJ	B-NP	O
gallstone	gallstone	NN	I-NP	O
Impression	Impression	NN	I-NP	O
:	:	:	O	O
73F	73F	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
non-specific	non-specific	JJ	I-NP	O
nausea	nausea	NN	I-NP	O
and	and	CC	I-NP	O
fatigue	fatigue	NN	I-NP	O
,	,	,	O	O
?	?	.	O	O

PNA	PNA	NN	B-NP	O
on	on	IN	B-PP	O
CXR	CXR	NN	B-NP	B-protein
,	,	,	O	O
mildly	mildly	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
lipase	lipase	NN	I-NP	O
suggesting	suggest	VBG	B-VP	O
passed	pass	VBN	B-NP	O
stone	stone	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pulm	Pulm	NNP	I-NP	O
:	:	:	O	O
?	?	.	O	O

IPF	IPF	NN	B-NP	B-protein
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
prior	prior	JJ	B-NP	O
CTs	CT	NNS	I-NP	O
,	,	,	O	O
now	now	RB	B-ADJP	O
w	w	JJ	I-ADJP	O
/	/	SYM	B-NP	O
productive	productive	JJ	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

Sputum	Sputum	NNP	B-NP	O
sent	send	VBD	B-VP	O
,	,	,	O	O
U	U	NN	B-NP	O
legionella	legionella	NN	I-NP	O
,	,	,	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
levoflox	levoflox	NN	B-NP	O
x	x	SYM	B-NP	O
10d	10d	CD	I-NP	O
.	.	.	O	O

COnt	COnt	NN	B-NP	O
antbx	antbx	NN	I-NP	O
for	for	IN	B-PP	O
8	8	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

Cont	Cont	JJ	B-NP	O
nebs	neb	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
steroids	steroid	NNS	I-NP	O
.	.	.	O	O

Will	Will	MD	O	O
have	have	VBP	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
consult	consult	NN	I-NP	O
today	today	NN	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
cont	cont	VB	B-VP	O
current	current	JJ	B-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
,	,	,	O	O
BB	BB	NN	B-NP	B-protein
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
CCB	CCB	NN	B-NP	B-protein
,	,	,	O	O
lasix	lasix	NN	B-NP	O
,	,	,	O	O
fibrate	fibrate	NN	B-NP	O
.	.	.	O	O

Enzymes	Enzyme	NNS	B-NP	B-protein
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
EKG	EKG	NN	B-NP	O
unchanged	unchanged	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
ACS	ACS	NN	B-NP	B-protein
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Heme	Heme	NNP	I-NP	O
:	:	:	O	O
anemia	anemia	NN	B-NP	O
x	x	SYM	O	O
2	2	CD	B-NP	O
yrs	yr	NNS	I-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
unclear	unclear	JJ	B-ADJP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
prior	prior	JJ	I-NP	O
work	work	NN	I-NP	O
up	up	RP	B-PRT	O
.	.	.	O	O

Fe	Fe	NN	B-NP	O
studies	study	NNS	I-NP	O
pending	pende	VBG	B-VP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
dose	dose	NN	I-NP	O
decrease	decrease	VB	B-VP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
Levo	Levo	NNP	B-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
5	5	CD	B-NP	O
qd	qd	NN	I-NP	O
once	once	IN	B-SBAR	O
abx	abx	NN	B-NP	O
completed	complete	VBN	B-VP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
GI	GI	NN	I-NP	O
:	:	:	O	O
mildly	mildly	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
lipase	lipase	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
at	at	IN	B-PP	O
177	177	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
d/c	d/c	NN	B-NP	O
lipase	lipase	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
93	93	CD	B-NP	O
and	and	CC	O	O
patient	patient	NN	B-NP	O
tolerating	tolerating	JJ	I-NP	O
POs	PO	NNS	I-NP	O
.	.	.	O	O

May	May	MD	O	O
need	need	VBP	B-VP	O
surgery	surgery	NN	B-NP	O
f/u	f/u	NN	I-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
to	to	TO	B-VP	O
decide	decide	VB	I-VP	O
on	on	IN	B-PP	O
elective	elective	JJ	B-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Endo	Endo	NNP	I-NP	O
:	:	:	O	O
DM	DM	NN	B-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
d/c	d/c	NN	B-NP	O
'd	'd	MD	B-VP	O
glucovance	glucovance	VB	I-VP	O
given	give	VBN	I-VP	O
Cr	Cr	NN	B-NP	O
>	>	SYM	O	O
1.4	1.4	CD	B-NP	O
,	,	,	O	O
cont	cont	NN	B-NP	O
'd	'd	MD	B-NP	O
insulin	insulin	NN	I-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
40/20	40/20	CD	I-NP	I-protein
,	,	,	O	O
increase	increase	NN	B-NP	O
prn	prn	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Dispo	Dispo	NNP	I-NP	O
:	:	:	O	O
d/c	d/c	NN	B-NP	O
to	to	TO	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
rehab	rehab	NN	I-NP	O
10/22	10/22	CD	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
PLCP	PLCP	NN	I-NP	B-protein
with	with	IN	B-PP	O
any	any	DT	B-NP	O
increasing	increase	VBG	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
difficulty	difficulty	NN	B-NP	O
breathing	breathing	NN	I-NP	O
at	at	IN	B-ADVP	O
all	all	DT	I-ADVP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
should	should	MD	O	O
you	you	PRP	B-NP	O
have	have	VB	B-VP	O
any	any	DT	B-NP	O
nausea	nausea	NN	I-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
see	see	VB	B-VP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Pulmonology	Pulmonology	NN	B-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

May	May	MD	O	O
need	need	VBP	B-VP	O
repeat	repeat	NN	B-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
and	and	CC	O	O
PFT	PFT	NN	B-NP	B-protein
's	's	POS	B-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Vise	Vise	NNP	I-NP	O
re	re	NN	I-NP	O
:	:	:	O	O
anemia	anemia	NN	B-NP	O
workup	workup	NN	I-NP	O
.	.	.	O	O

SHould	SHould	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

Has	Ha	NNS	B-NP	B-protein
been	be	VBN	B-VP	O
years	year	NNS	B-NP	O
since	since	IN	B-SBAR	O
flex	flex	NN	B-NP	B-protein
sig	sig	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Vasular	Vasular	JJ	B-NP	O
studies	study	NNS	I-NP	O
of	of	IN	B-PP	O
legs	leg	NNS	B-NP	O
for	for	IN	B-PP	O
claudication	claudication	NN	B-NP	O
planned	plan	VBN	B-VP	O
on	on	IN	B-PP	O
June	June	NNP	B-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

F/U	F/U	NN	B-NP	B-protein
coumadin	coumadin	NN	I-NP	I-protein
labs	lab	NNS	I-NP	I-protein
.	.	.	O	O

Dose	Dose	NN	B-NP	O
decreased	decrease	VBD	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
patient	patient	NN	B-NP	O
being	be	VBG	B-VP	O
on	on	IN	B-PP	O
Levo	Levo	NNP	B-NP	O
.	.	.	O	O

Get	Get	NN	B-NP	O
INR	INR	NN	I-NP	O
check	check	NN	I-NP	O
on	on	IN	B-PP	O
friday	friday	NN	B-NP	O
,	,	,	O	O
then	then	RB	O	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
5	5	CD	B-NP	O
.	.	.	O	O

COntinue	COntinue	NNP	B-NP	O
Levo	Levo	NNP	I-NP	O
x8	x8	NN	I-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
d/c	d/c	NN	B-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SHEFFEL	SHEFFEL	NNP	B-NP	O
,	,	,	O	O
CHANCE	CHANCE	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HG16	HG16	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/14/04	7/14/04	CD	I-NP	O
@	@	SYM	B-NP	O
02	02	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

